http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1835300-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70549206888133ec7f9149149b3fb684
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067
filingDate 1990-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a1806fd8e573e9e0c5769c02320ee5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e39c4007849655598bbb34527f850741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20f80fe564276af1fa0f9d1fa7a1f4fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63f0cd330247b460a706d28a4e82bdac
publicationDate 1993-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-1835300-C
titleOfInvention A new method of treatment of pulmonary tuberculosis
abstract Usage: in TB. SUMMARY OF THE INVENTION: Patients with a tuberculin-Leukocytolysis response of less than 15% are irradiated with low-intensity laser radiation from the interscapular region at the level of II, III, IV thoracic vertebrae on the affected side 24 hours after the next administration of tuberculin. Moreover, the full course of treatment is carried out for persons in whom, after 24 hours after the first laser exposure and 48 hours after the first injection of tuberculin, the tuberculin-leukocytolysis reaction rates increase to 15% or more. The beneficial effect allows a reduction in treatment time in patients with suppressed immunological reactivity.
priorityDate 1990-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID444374
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO19062
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554054
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ07203
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48199
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02741
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163606
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743192
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1401
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14847
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396842
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49254
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2761171
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49262
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID751795

Total number of triples: 38.